| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide Synthase | 12 | 2007 | 74 | 1.410 |
Why?
|
| Penis | 17 | 2008 | 110 | 1.380 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 21 | 0.980 |
Why?
|
| Genetic Therapy | 4 | 2007 | 18 | 0.760 |
Why?
|
| Rats | 23 | 2012 | 432 | 0.760 |
Why?
|
| Erectile Dysfunction | 4 | 2007 | 37 | 0.740 |
Why?
|
| Animals | 28 | 2012 | 1238 | 0.720 |
Why?
|
| Apoptosis | 3 | 2014 | 162 | 0.620 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 32 | 0.600 |
Why?
|
| Penile Induration | 7 | 2008 | 34 | 0.600 |
Why?
|
| Tretinoin | 4 | 2000 | 13 | 0.570 |
Why?
|
| Aging | 7 | 2010 | 101 | 0.550 |
Why?
|
| Male | 24 | 2011 | 1649 | 0.550 |
Why?
|
| Carrier Proteins | 5 | 2011 | 22 | 0.510 |
Why?
|
| Transforming Growth Factor beta | 6 | 2008 | 81 | 0.500 |
Why?
|
| Diabetes, Gestational | 1 | 2014 | 10 | 0.500 |
Why?
|
| Models, Biological | 1 | 2014 | 43 | 0.490 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 17 | 0.490 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 12 | 0.490 |
Why?
|
| Placenta | 1 | 2014 | 27 | 0.490 |
Why?
|
| Malnutrition | 2 | 2011 | 23 | 0.480 |
Why?
|
| DNA-Binding Proteins | 4 | 2002 | 25 | 0.470 |
Why?
|
| Down-Regulation | 6 | 2011 | 52 | 0.460 |
Why?
|
| Transcription Factors | 6 | 2011 | 42 | 0.460 |
Why?
|
| Fetal Growth Retardation | 2 | 2012 | 35 | 0.430 |
Why?
|
| RNA, Messenger | 14 | 2014 | 167 | 0.430 |
Why?
|
| Signal Transduction | 2 | 2011 | 180 | 0.400 |
Why?
|
| Nephrons | 1 | 2011 | 2 | 0.400 |
Why?
|
| Receptors, Notch | 1 | 2011 | 8 | 0.400 |
Why?
|
| Kidney Diseases | 1 | 2011 | 18 | 0.400 |
Why?
|
| Pregnancy | 8 | 2014 | 305 | 0.400 |
Why?
|
| Humans | 18 | 2014 | 2493 | 0.390 |
Why?
|
| Rats, Inbred F344 | 10 | 2008 | 60 | 0.390 |
Why?
|
| Nitric Oxide | 2 | 2008 | 54 | 0.390 |
Why?
|
| Female | 10 | 2014 | 1733 | 0.370 |
Why?
|
| Muscle, Skeletal | 2 | 2008 | 87 | 0.360 |
Why?
|
| Gene Transfer Techniques | 2 | 2006 | 9 | 0.360 |
Why?
|
| Penile Erection | 7 | 2007 | 33 | 0.360 |
Why?
|
| Endometrium | 2 | 2008 | 22 | 0.360 |
Why?
|
| Smoke | 1 | 2008 | 2 | 0.350 |
Why?
|
| Tobacco | 1 | 2008 | 3 | 0.340 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2008 | 3 | 0.340 |
Why?
|
| Epithelial Cells | 1 | 2008 | 29 | 0.340 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2003 | 20 | 0.340 |
Why?
|
| Cell Proliferation | 1 | 2008 | 110 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2012 | 179 | 0.320 |
Why?
|
| Repressor Proteins | 2 | 2011 | 9 | 0.320 |
Why?
|
| Gene Expression | 6 | 2006 | 73 | 0.290 |
Why?
|
| Up-Regulation | 3 | 2008 | 71 | 0.290 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 9 | 0.290 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2012 | 60 | 0.270 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 92 | 0.270 |
Why?
|
| Nitric Oxide Synthase Type I | 6 | 2007 | 30 | 0.270 |
Why?
|
| Phosphoproteins | 3 | 2000 | 6 | 0.270 |
Why?
|
| Blotting, Western | 7 | 2008 | 116 | 0.260 |
Why?
|
| Gene Expression Regulation | 2 | 2002 | 93 | 0.260 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2000 | 32 | 0.230 |
Why?
|
| Liver Neoplasms | 2 | 2000 | 45 | 0.220 |
Why?
|
| Nuclear Proteins | 2 | 2000 | 7 | 0.220 |
Why?
|
| Base Sequence | 8 | 2006 | 65 | 0.220 |
Why?
|
| Immediate-Early Proteins | 1 | 2002 | 3 | 0.220 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 36 | 0.220 |
Why?
|
| Food Deprivation | 2 | 2012 | 9 | 0.210 |
Why?
|
| DNA, Complementary | 4 | 2004 | 18 | 0.210 |
Why?
|
| Plasmids | 4 | 2006 | 16 | 0.200 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 2000 | 1 | 0.190 |
Why?
|
| Fatty Acids | 1 | 2000 | 13 | 0.190 |
Why?
|
| Electroporation | 3 | 2006 | 10 | 0.190 |
Why?
|
| Genetic Vectors | 3 | 2006 | 16 | 0.190 |
Why?
|
| Fatty Liver | 2 | 2012 | 53 | 0.190 |
Why?
|
| Liver | 2 | 2012 | 120 | 0.180 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2000 | 5 | 0.180 |
Why?
|
| alpha-Fetoproteins | 1 | 1998 | 5 | 0.170 |
Why?
|
| Mice | 6 | 2006 | 508 | 0.170 |
Why?
|
| Stem Cells | 3 | 2008 | 28 | 0.170 |
Why?
|
| Fetal Development | 2 | 2008 | 21 | 0.170 |
Why?
|
| Cell Differentiation | 4 | 2008 | 79 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1998 | 77 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 17 | 0.150 |
Why?
|
| Urinary Tract | 1 | 1996 | 4 | 0.150 |
Why?
|
| Cell Line | 4 | 2008 | 80 | 0.150 |
Why?
|
| Transfection | 4 | 2006 | 46 | 0.150 |
Why?
|
| Neurons | 1 | 1996 | 41 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 118 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2008 | 46 | 0.140 |
Why?
|
| Cells, Cultured | 5 | 2008 | 164 | 0.140 |
Why?
|
| Time Factors | 2 | 2008 | 120 | 0.130 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 2 | 0.130 |
Why?
|
| Term Birth | 1 | 2014 | 4 | 0.130 |
Why?
|
| Placentation | 1 | 2014 | 5 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 28 | 0.120 |
Why?
|
| Birth Weight | 1 | 2014 | 22 | 0.120 |
Why?
|
| Wnt Proteins | 2 | 2011 | 9 | 0.120 |
Why?
|
| Fibrosis | 5 | 2008 | 63 | 0.120 |
Why?
|
| beta-Galactosidase | 2 | 2002 | 6 | 0.110 |
Why?
|
| Adenoviridae | 2 | 2002 | 9 | 0.110 |
Why?
|
| Electric Stimulation | 2 | 2002 | 10 | 0.110 |
Why?
|
| Immunohistochemistry | 7 | 2008 | 133 | 0.110 |
Why?
|
| Myostatin | 3 | 2008 | 47 | 0.110 |
Why?
|
| Adult | 1 | 2014 | 807 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 3 | 2000 | 3 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2000 | 7 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2007 | 143 | 0.100 |
Why?
|
| Steroids | 1 | 2011 | 7 | 0.100 |
Why?
|
| Adrenal Glands | 1 | 2011 | 12 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 10 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 13 | 0.100 |
Why?
|
| Fibroblasts | 3 | 2008 | 26 | 0.090 |
Why?
|
| Aorta | 1 | 2010 | 16 | 0.090 |
Why?
|
| Muscle, Smooth | 5 | 2005 | 36 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 10 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 18 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 67 | 0.090 |
Why?
|
| Amino Acid Sequence | 5 | 2004 | 45 | 0.090 |
Why?
|
| Benzo(a)pyrene | 1 | 2008 | 2 | 0.090 |
Why?
|
| Hemoglobins | 1 | 2008 | 3 | 0.090 |
Why?
|
| Follicular Phase | 1 | 2008 | 3 | 0.090 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 3 | 0.090 |
Why?
|
| Premenopause | 1 | 2008 | 5 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2008 | 9 | 0.090 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2008 | 7 | 0.090 |
Why?
|
| Glutathione | 1 | 2008 | 13 | 0.090 |
Why?
|
| Colon | 1 | 2008 | 16 | 0.090 |
Why?
|
| Arginine | 1 | 2008 | 19 | 0.090 |
Why?
|
| Lipase | 1 | 2008 | 3 | 0.090 |
Why?
|
| Fatty Acid Synthases | 1 | 2008 | 6 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2008 | 4 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2006 | 9 | 0.080 |
Why?
|
| Antioxidants | 1 | 2008 | 20 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2008 | 11 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2008 | 7 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 9 | 0.080 |
Why?
|
| Triglycerides | 1 | 2008 | 36 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 17 | 0.080 |
Why?
|
| Nicotinic Agonists | 1 | 2008 | 27 | 0.080 |
Why?
|
| Kidney | 1 | 2008 | 36 | 0.080 |
Why?
|
| Aquaporin 1 | 1 | 2008 | 3 | 0.080 |
Why?
|
| Trophoblasts | 1 | 2008 | 4 | 0.080 |
Why?
|
| Cyclic AMP | 1 | 2008 | 9 | 0.080 |
Why?
|
| Arginine Vasopressin | 1 | 2008 | 45 | 0.080 |
Why?
|
| Impotence, Vasculogenic | 1 | 2008 | 14 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 14 | 0.080 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2008 | 28 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 62 | 0.080 |
Why?
|
| Nicotine | 1 | 2008 | 89 | 0.080 |
Why?
|
| Lac Operon | 1 | 2006 | 4 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2006 | 6 | 0.070 |
Why?
|
| Dyneins | 2 | 2003 | 4 | 0.070 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2006 | 4 | 0.070 |
Why?
|
| Carbolines | 1 | 2006 | 4 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2003 | 24 | 0.070 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2006 | 21 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2003 | 112 | 0.070 |
Why?
|
| Mesoderm | 1 | 2005 | 9 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 8 | 0.070 |
Why?
|
| Adipocytes | 1 | 2005 | 26 | 0.070 |
Why?
|
| Adenosine Monophosphate | 1 | 2004 | 2 | 0.070 |
Why?
|
| Luciferases | 1 | 2004 | 5 | 0.070 |
Why?
|
| Genitalia, Female | 1 | 2004 | 3 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2001 | 28 | 0.060 |
Why?
|
| Ligands | 2 | 2000 | 15 | 0.060 |
Why?
|
| DNA Primers | 2 | 2005 | 17 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2003 | 14 | 0.060 |
Why?
|
| Nervous System | 1 | 2003 | 2 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2003 | 47 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 2 | 2000 | 2 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2000 | 2 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2000 | 2 | 0.060 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2002 | 2 | 0.050 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2002 | 2 | 0.050 |
Why?
|
| Pancreatic Elastase | 1 | 2002 | 3 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2002 | 12 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 52 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2002 | 12 | 0.050 |
Why?
|
| Retinoid X Receptors | 2 | 2000 | 6 | 0.050 |
Why?
|
| Cytokines | 1 | 2002 | 47 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 1998 | 25 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2012 | 54 | 0.050 |
Why?
|
| Tyrosine | 1 | 2001 | 6 | 0.050 |
Why?
|
| Response Elements | 1 | 2000 | 4 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2000 | 11 | 0.050 |
Why?
|
| Prostate | 1 | 2000 | 10 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 4 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 1997 | 16 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 1997 | 35 | 0.050 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 1998 | 1 | 0.040 |
Why?
|
| Teratoma | 1 | 1998 | 2 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1998 | 6 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 34 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1998 | 16 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2008 | 24 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2008 | 13 | 0.030 |
Why?
|
| Myoblasts | 2 | 2005 | 12 | 0.030 |
Why?
|
| Adenylate Kinase | 1 | 2012 | 3 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2012 | 11 | 0.030 |
Why?
|
| Body Weight | 1 | 2012 | 65 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2005 | 33 | 0.030 |
Why?
|
| Collagen | 2 | 2002 | 26 | 0.030 |
Why?
|
| Enzyme Induction | 2 | 2002 | 15 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 90 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 26 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2010 | 41 | 0.020 |
Why?
|
| Myenteric Plexus | 1 | 2008 | 3 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 13 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 14 | 0.020 |
Why?
|
| Sheep | 1 | 2008 | 100 | 0.020 |
Why?
|
| Ureter | 1 | 2008 | 2 | 0.020 |
Why?
|
| PAX2 Transcription Factor | 1 | 2008 | 2 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Wnt4 Protein | 1 | 2008 | 2 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 5 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 6 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2008 | 5 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2008 | 4 | 0.020 |
Why?
|
| Thionucleotides | 1 | 2008 | 2 | 0.020 |
Why?
|
| Colforsin | 1 | 2008 | 5 | 0.020 |
Why?
|
| Fetus | 1 | 2008 | 96 | 0.020 |
Why?
|
| Tadalafil | 1 | 2006 | 4 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2006 | 13 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 39 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2005 | 2 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2005 | 2 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2005 | 3 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 6 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 4 | 0.020 |
Why?
|
| Multipotent Stem Cells | 1 | 2005 | 9 | 0.020 |
Why?
|
| Azacitidine | 1 | 2005 | 4 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2005 | 5 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2005 | 38 | 0.020 |
Why?
|
| Biomarkers | 1 | 2005 | 58 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2005 | 42 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 2004 | 9 | 0.020 |
Why?
|
| Xanthine Oxidase | 1 | 2004 | 2 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2004 | 4 | 0.020 |
Why?
|
| Testis | 1 | 2004 | 16 | 0.020 |
Why?
|
| Injections | 1 | 2004 | 11 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 30 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2003 | 7 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 18 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 45 | 0.010 |
Why?
|
| Vimentin | 1 | 2002 | 3 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2002 | 15 | 0.010 |
Why?
|
| Actins | 1 | 2002 | 17 | 0.010 |
Why?
|
| Peroxynitrous Acid | 1 | 2002 | 4 | 0.010 |
Why?
|
| Models, Animal | 1 | 2002 | 16 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 36 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 7 | 0.010 |
Why?
|
| Nitrates | 1 | 2001 | 6 | 0.010 |
Why?
|
| RNA | 1 | 2001 | 16 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 19 | 0.010 |
Why?
|
| Ubiquitins | 1 | 2001 | 13 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 13 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 13 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 13 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2001 | 32 | 0.010 |
Why?
|
| Binding Sites | 1 | 2000 | 14 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 9 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 19 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 2000 | 10 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2000 | 7 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 3 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2000 | 11 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2000 | 37 | 0.010 |
Why?
|
| Galactokinase | 1 | 1998 | 1 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1998 | 1 | 0.010 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1998 | 1 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 1998 | 3 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1998 | 5 | 0.010 |
Why?
|
| Mutation | 1 | 1998 | 28 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 1997 | 4 | 0.010 |
Why?
|
| Codon | 1 | 1997 | 4 | 0.010 |
Why?
|